2011

New article in Berlingske Nyhedsmagasin: "Medicovirksomhed jagter vækst i Afrika"

ViroGates has been granted a new patent to measure the risk of developing life style related diseases using its suPARnostic® biomarker product 

ViroGates enters into agreement with Danish Cancer Research Foundation 

Jakob Knudsen appointed as new CEO at ViroGates